696 related articles for article (PubMed ID: 23404677)
1. First experiences with the GORE(®) Septal Occluder in children and adults with atrial septal defects.
Nyboe C; Hjortdal VE; Nielsen-Kudsk JE
Catheter Cardiovasc Interv; 2013 Nov; 82(6):929-34. PubMed ID: 23404677
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter closure of atrial septal defects in children and adolescents: single-center experience with the GORE® septal occluder.
Grohmann J; Höhn R; Fleck T; Schmoor C; Stiller B
Catheter Cardiovasc Interv; 2014 Nov; 84(6):E51-7. PubMed ID: 24664494
[TBL] [Abstract][Full Text] [Related]
3. Initial clinical experience with the GORE
de Hemptinne Q; Horlick EM; Osten MD; Millán X; Tadros VX; Pighi M; Gonzalez Barlatey F; Alnasser SM; Miró J; Asgar AW; Ibrahim R
Catheter Cardiovasc Interv; 2017 Sep; 90(3):495-503. PubMed ID: 28128523
[TBL] [Abstract][Full Text] [Related]
4. Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients.
Grohmann J; Wildberg C; Zartner P; Abu-Tair T; Tarusinov G; Kitzmüller E; Schmoor C; Stiller B; Kampmann C
Catheter Cardiovasc Interv; 2017 Jun; 89(7):E226-E232. PubMed ID: 27900839
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized trial of transthoracic echocardiography versus transesophageal echocardiography for assessment and guidance of transcatheter closure of atrial septal defects in children using the Amplatzer septal occluder.
Bartakian S; El-Said HG; Printz B; Moore JW
JACC Cardiovasc Interv; 2013 Sep; 6(9):974-80. PubMed ID: 24050864
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and safety of a new generation of gore septal occluder device in children.
Lombardi M; Tagliente MR; Pirolo T; Massari E; Milella L; Vairo U
J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e249-e251. PubMed ID: 24721761
[TBL] [Abstract][Full Text] [Related]
7. Use of the GORE® CARDIOFORM Septal Occluder for percutaneous closure of secundum atrial septal defects: Results of the multicenter U.S. IDE trial.
Gillespie MJ; Javois AJ; Moore P; Forbes T; Paolillo JA;
Catheter Cardiovasc Interv; 2020 Jun; 95(7):1296-1304. PubMed ID: 32108423
[TBL] [Abstract][Full Text] [Related]
8. Clinical results of large secundum atrial septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder.
Lairakdomrong K; Srimahachota S; Lertsapcharoen P; Chaipromprasit J; Boonyaratavej S; Kaewsukkho P
J Med Assoc Thai; 2013 Sep; 96(9):1127-34. PubMed ID: 24163987
[TBL] [Abstract][Full Text] [Related]
9. Novel delivery technique for atrial septal defect closure in young children utilizing the GORE
Anderson JH; Fraint H; Moore P; Cabalka AK; Taggart NW
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1232-1238. PubMed ID: 27896910
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal Occluder.
Godart F; Houeijeh A; Recher M; Francart C; Polge AS; Richardson M; Cajot MA; Duhamel A
Arch Cardiovasc Dis; 2015 Jan; 108(1):57-63. PubMed ID: 25453168
[TBL] [Abstract][Full Text] [Related]
11. First experience with the new GORE Septal Occluder for the closure of multiple atrial septal defects.
Freixa X; Garceau P; Asgar AW
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1238-42. PubMed ID: 22639117
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of transcatheter closure in unselected patients with secundum atrial septal defect, using Amplatzer devices and a modified sizing balloon technique.
Kammache I; Mancini J; Ovaert C; Habib G; Fraisse A
Catheter Cardiovasc Interv; 2011 Nov; 78(5):665-74. PubMed ID: 21812090
[TBL] [Abstract][Full Text] [Related]
13. ASSURED clinical study: New GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect.
Sommer RJ; Love BA; Paolillo JA; Gray RG; Goldstein BH; Morgan GJ; Gillespie MJ;
Catheter Cardiovasc Interv; 2020 Jun; 95(7):1285-1295. PubMed ID: 31943749
[TBL] [Abstract][Full Text] [Related]
14. Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement.
Amin Z
Catheter Cardiovasc Interv; 2014 Jan; 83(1):84-92. PubMed ID: 24038861
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of Cardi-O-Fix septal occluder versus Amplatzer septal occluder in percutaneous closure of secundum atrial septal defects.
Saritas T; Kaya MG; Lam YY; Erdem A; Akdeniz C; Demir F; Erol N; Demir H; Celebi A
Catheter Cardiovasc Interv; 2013 Jul; 82(1):116-21. PubMed ID: 21805616
[TBL] [Abstract][Full Text] [Related]
16. Results of the U.S. Food and Drug Administration continued access clinical trial of the GORE HELEX septal occluder for secundum atrial septal defect.
Javois AJ; Rome JJ; Jones TK; Zahn EM; Fleishman CE; Pignatelli RH; Latson LA;
JACC Cardiovasc Interv; 2014 Aug; 7(8):905-12. PubMed ID: 25147036
[TBL] [Abstract][Full Text] [Related]
17. Immediate and short-term outcomes after percutaneous atrial septal defect closure using the new nit-occlud ASD-R device.
Peirone A; Contreras A; Ferrero A; da Costa RN; Pedra SF; Pedra CA
Catheter Cardiovasc Interv; 2014 Sep; 84(3):464-70. PubMed ID: 24677704
[TBL] [Abstract][Full Text] [Related]
18. UK multicenter experience using the Gore septal occluder (GSO(TM) ) for atrial septal defect closure in children and adults.
Smith B; Thomson J; Crossland D; Spence MS; Morgan GJ
Catheter Cardiovasc Interv; 2014 Mar; 83(4):581-6. PubMed ID: 24115686
[TBL] [Abstract][Full Text] [Related]
19. Combined prospective United States clinical study data for the GORE(®) HELEX(®) septal occluder device.
Rhodes JF; Goble J
Catheter Cardiovasc Interv; 2014 May; 83(6):944-52. PubMed ID: 23674380
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter closure of atrial septal defects in adults > or =40 years of age: immediate and follow-up results.
Patel A; Lopez K; Banerjee A; Joseph A; Cao QL; Hijazi ZM
J Interv Cardiol; 2007 Feb; 20(1):82-8. PubMed ID: 17300410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
